Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Checkout and shipment stay gated until lot-linked documentation is verified
The controlled injury itself triggers wound healing responses
This is consistent with FY2026 CMS guidance for Z code screening categories
FDA regulatory shifts in 2023 to 2024 moved BPC-157 and other compounds to "Category 2" status, requiring strict 503A/503B medical-grade sourcing for legal clinical use
Modifier 59 Modifier 59 indicates a distinct procedural service and applies in specific payer-edit scenarios
These improvements position the compound as valuable for investigating the NAD+ metabolic basis of insulin resistance and diabetes pathophysiology
US$ 26.89
US$ 22.45
US$ 26.42
US$ 25.65
US$ 26.98
US$ 25.82
US$ 27.57
US$ 20.60
